Αποτελέσματα Αναζήτησης
Background. Peptic ulcer disease (PUD) remains common in many parts of the Asia-Pacific region in spite of an overall decrease in incidence and prevalence worldwide. Several population-based studies from the US and Europe showed annual incidence rates of 0.10–0.19% for physician-diagnosed PUD, and 0.03–0.17% for hospital-based diagnosis.
practice guidelines for peptic ulcer disease in 2020 and created an English version. The revised guidelines consist of nine items: epidemiology, hemorrhagic gastric and duodenal ulcers, Helicobacter pylori (H. pylori) eradica-tion therapy, non-eradication therapy, drug-induced ulcers, non-H. pylori, and nonsteroidal anti-inflammatory drug
12 Οκτ 2021 · Peptic ulcers are caused by an imbalance between aggressive factors like hydrochloric acid (HCL), pepsin, refluxed bile, leukotrienes (LTs), reactive oxygen species (ROS), and defensive factors...
23 Φεβ 2021 · The revised guidelines consist of nine items: epidemiology, hemorrhagic gastric and duodenal ulcers, Helicobacter pylori ( H. pylori ) eradication therapy, non-eradication therapy, drug-induced...
7 Ιαν 2020 · We divided our work into the two main topics, bleeding and perforated peptic ulcer, and structured it into six main topics that cover the entire management process of patients with complicated peptic ulcer, from diagnosis at ED arrival to post-discharge antimicrobial therapy, to provide an up-to-date, easy-to-use tool that can help physicians ...
23 Φεβ 2021 · The revised guidelines consist of nine items: epidemiology, hemorrhagic gastric and duodenal ulcers, Helicobacter pylori (H. pylori) eradication therapy, non-eradication therapy, drug-induced ulcers, non-H. pylori, and nonsteroidal anti-inflammatory drug (NSAID) ulcers, remnant gastric ulcers, surgical treatment, and conservative therapy for ...
3 Ιαν 2019 · Timely diagnosis and treatment of peptic ulcer disease and its sequelae are crucial in order to minimize associated morbidity and mortality, as is prevention of peptic ulcer disease among patients at high risk, including those infected with H. pylori and users of NSAIDs.
